Bloomios (Bloomios) Total Revenue Growth Rate (Future 3Y To 5Y Est) : N/A (As of Jun. 21, 2024)

View and export this data going back to 2003. Start your Free Trial

What is Bloomios Total Revenue Growth Rate (Future 3Y To 5Y Est)?

Total Revenue Growth Rate (Future 3Y To 5Y Est) is the average growth rate of total revenue estimates over a 3-year to 5-year period.

As of today, Bloomios's Total Revenue Growth Rate (Future 3Y To 5Y Est) is N/A.

Competitive Comparison of Bloomios's Total Revenue Growth Rate (Future 3Y To 5Y Est)

For the Drug Manufacturers - Specialty & Generic subindustry, Bloomios's Total Revenue Growth Rate (Future 3Y To 5Y Est), along with its competitors' market caps and Total Revenue Growth Rate (Future 3Y To 5Y Est) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bloomios's Total Revenue Growth Rate (Future 3Y To 5Y Est) Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bloomios's Total Revenue Growth Rate (Future 3Y To 5Y Est) distribution charts can be found below:

* The bar in red indicates where Bloomios's Total Revenue Growth Rate (Future 3Y To 5Y Est) falls into.

Bloomios (OTCPK:BLMS) Total Revenue Growth Rate (Future 3Y To 5Y Est) Explanation

Total Revenue Growth Rate (Future 3Y To 5Y Est) is the growth rate of total revenue estimates over a 3-year to 5-year period. This data is provided directly by our trusted data vendors Refinitiv or Morningstar.

In situations where both vendors do not directly provide the growth rate data, we use the most recent annual revenue for the current year and estimated future revenue figures provided by the vendor to calculate the growth rate. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average total revenue estimates growth rate.

Bloomios Total Revenue Growth Rate (Future 3Y To 5Y Est) Related Terms

Thank you for viewing the detailed overview of Bloomios's Total Revenue Growth Rate (Future 3Y To 5Y Est) provided by GuruFocus.com. Please click on the following links to see related term pages.

Bloomios (Bloomios) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bloomios Inc (OTCPK:BLMS) » Definitions » Total Revenue Growth Rate (Future 3Y To 5Y Est)

Comparable Companies

Traded in Other Exchanges

N/A

Address

701 Anacapa Street, Suite C, Santa Barbara, CA, USA, 93101

Website

https://www.bloomios.com

Bloomios Inc manufactures, markets, and distributes U.S. hemp-derived supplements and cosmetic products through wholesale distribution channels in the United States of America. It offers its private-label and white-label customers large collections of customizable hemp products that include over 80 products across 7 categories in addition to custom formulation and manufacturing services. Its product categories include edibles, tinctures, oils, salves, capsules, balms, lotions, creams, beverages, and pet treats.

Executives

Douglas S Rohrer	officer: Chief Business Officer	701 ANACAPA, SUITE C, SANTA BARBARA CA 93101
Emc2 Capital Llc	10 percent owner	201 W MONTECITO STREET, SANTA BARBARA CA 93101
Barrett Evans	director, 10 percent owner, officer: Pres, Chief Strategy Officer
Aline Hayuta Elkayam	10 percent owner	104 CHELSEA PLACE, ORMOND BEACH FL 32174
Bibi Daprile	10 percent owner	12 WINDING CREEK WAY, ORMOND BEACH FL 32174
Agpl Acquisition, Inc	10 percent owner	201 W MONTECITO ST., SANTA BARBARA CA 93101
Mammoth Crest Capital Llc	10 percent owner	1712 PIONEER AVE, SUITE 558, CHEYENNE WY 82001
Michael Hill	director, 10 percent owner, officer: Chief Executive Officer	201 WEST MONTECITO STREET, SANTA BARBARA CA 93101
Bryan Glass	director, 10 percent owner, officer: President and Director	20 WEST PARK AVENUE, SUITE 207, LONG BEACH NY 11561
Douglas Boyd	director, officer: Chairman of the Board	8101 TIARA COVE CIR, LAS VEGAS NV 89128
Peter A Hogendoorn	director, officer: President & CEO	13288 AMBLE GREEN PLACE, SURREY A1 V4A 6P5
Harold C Moll	director, 10 percent owner
Van Laare Derek R	officer: Secretary	6119 GORDON AVENUE, BURNABY A1 V5E 3M2
Carlo Civelli	other: former director/officer/owner	111 SOMERSET ROAD, TRIPLE ONE SOMERSET 06-06, SINGAPORE U0 238164
Logan Anderson	director, officer: President & Treasurer	15 HILL CRESCENT, PEMBROKE BERMUDA D8 00000